AndrewJDannenbergMD
Gastroenterology • New York, NYProfessor, Medicine, Weill Cornell Medical College
Are you Dr. Dannenberg?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
You already have 76 invites waiting! - Read the latest clinical news, personalized to your specialty.
Office
525 E 68th St
# J-314
New York, NY 10065Phone+1 212-746-1339Fax+1 212-746-3426
Summary
- Dr. Andrew Dannenberg, MD is a gastroenterologist in New York, New York. He is currently licensed to practice medicine in New York. He is affiliated with New York-Presbyterian Hospital and is a Professor at Weill Cornell Medical College.
Education & Training
New York Presbyterian Hospital (Cornell Campus)Fellowship, Gastroenterology, 1985 - 1988- New York Presbyterian Hospital (Cornell Campus)Residency, Internal Medicine, 1982 - 1985
Washington University in St. Louis School of MedicineClass of 1982
Certifications & Licensure
NY State Medical License 1983 - 2024
American Board of Internal Medicine Internal Medicine- American Board of Internal Medicine Gastroenterology
Awards, Honors, & Recognition
- Elected Member The American Society for Clinical Investigation, 2001
Publications & Presentations
PubMed
- Associations of Lifestyle and Genetic Risks with Obesity and Related Chronic Diseases in the UK Biobank: A Prospective Cohort Study.Yanbo Zhang, Yang Li, Rita Peila, Tao Wang, Xiaonan Xue
The American Journal of Clinical Nutrition. 2024-06-01 - Pharmacological Characterization of SDX-7320/Evexomostat: A Novel Methionine Aminopeptidase Type 2 Inhibitor with Anti-tumor and Anti-metastatic Activity.Peter Cornelius, Benjamin A Mayes, John S Petersen, David J Turnquist, Pierre J Dufour
Molecular Cancer Therapeutics. 2024-05-02 - A randomized, double-blind, placebo-controlled phase 2 study to assess safety, tolerability, and efficacy of RT001 in patients with amyotrophic lateral sclerosis.Daphne N Weemering, Mark Midei, Peter Milner, Vidhya Gopalakrishnan, Anil Kumar
European Journal of Neurology. 2023-12-01
Press Mentions
Icons of Healthcare & Therapeutic Garden Design Interview Series: Daniel Winterbottom, FASLAJune 24th, 2021
Diet High in Fiber May Protect Women Against Breast CancerMay 14th, 2020
Discovery of a New Immune Process Could Lead to Better Pain TreatmentsJuly 22nd, 2019- Join now to see all
Grant Support
- Targeting The Obesity-Inflammation-Cox-Aromatase Axis To Lower Breast Cancer RiskNational Cancer Institute2011
- COX-2: A Target For The Prevention Of Cervical CancerNational Cancer Institute2004–2008
- Urinary Pge-M, Biomarker Of Tobacco-Smoke Lung InjuryNational Center For Research Resources2006–2007
- Effects Of Cigarette Smoke On Cycloxygenase-2 In Oral MucosaNational Center For Research Resources2006–2007
- Cyclooxygenase 2 ABD Prevention Of Head And Neck CancerNational Cancer Institute2001–2005
- New Tharapy For HER 2/Neu Positive Breast CancerNational Cancer Institute2001–2004
- Retinoids Inhibit Cyclooxygenase And CarcinogenesisNational Cancer Institute1996–1998
- Modulation Of Xenobiotic Toxicity By DietNational Institute Of Diabetes And Digestive And Kidney Diseases1990–1994
